,outcome,arm 1,arm 2
0,intervention,,
0,"incidence of adverse events, cytomegalovirus (, herpes simplex, total study group","10.1 %, 11.3, 17.9, 19.0 %, 25.2, 3.2 %, 32.5 %, 37.3, 5.7 %, 9.5 %","10.1 %, 11.3, 17.9, 19.0 %, 25.2, 3.2 %, 32.5 %, 37.3, 5.7 %, 9.5 %"
